Explore our grantees and awardees

Grant category: Standalone grants

Year: 2021

Geography: Denmark

Add-on Grant for the Leo Foundation Skin Immunology Research Center. Herlev and Gentofte Hospital together with LEO Foundation Skin Immunology Research Center at the University of Copenhagen establish a new research program and biobank with skin tissue and blood samples from 3,000 patients with illnesses such as psoriasis and eczema. The biobank is the first of its kind and will help shed light on some of the most common skin diseases. The goal is to collect data from 3,000 patients with skin diseases and in the long term also making data and knowledge available for researchers around the world.

The research program is established by the LEO Foundation Skin Immunology Research Center at the University of Copenhagen and the Department of Dermatology and Allergy at Herlev and Gentofte Hospital.

The program is supported with DKK 40 million from the LEO Foundation and co-financed with DKK 20 million from Herlev and Gentofte Hospital and LEO Foundation Skin Immunology Research Center.

Read more

Grant category: Education and Awareness Grants

Year: 2021

Geography: Denmark

Unge Forskere is the largest talent competition in Denmark within STEM (Science, Technology, Engineering and Mathematics). Target group is students in primary school and high school.

Unge Forskere contributes to both talent development through participation in the competition and strengthens the work with innovation, idea development and the natural science method in daily teaching. Furthermore, it strengthens the natural science identity and the general science education among children and young people in Denmark.

More information

Grant category: Education and Awareness Grants

Year: 2021

Geography: Denmark

Bloom is an innovative festival about science and nature, which enlighten us on the universe, the World, and ourselves.

It takes place in the lush Søndermarken in the heart of Copenhagen, Denmark, where some of the World’s greatest scientists, poets and philosophers have found inspiration through history.

In recent years, Bloom has extended to become a year-round platform for science communication, which includes, e.g., the digital magazine Bloom Explore with videos, podcasts and essays, Summer Bloom at Geopark Odsherred, Bloom School targeted at 7^th – 9^th grade students, and a coming book series from Gyldendal.

By uniting the best from the worlds of festivals and science, Bloom aims to take on Life’s greatest questions through debates, talks, laboratories, conversations, and nature walks.

More information

Grant category: Education and Awareness Grants

Year: 2021

Geography: Denmark

Big Bang is Denmark’s largest conference for teachers, teacher students, didactics, and researchers involved in natural science education. The purpose of Big Bang is to strengthen participants’ network, cooperation, and knowledge sharing.

The conference is held annually and gathers more than 1,000 people for two inspiring days with relevant keynote speakers, a humming exhibition atmosphere, interactive workshops, and novel ideas for the continued renewal and improvement of the Danish natural science education.

As good teachers are essential in developing children’s interest, knowledge, and skills within the natural sciences, Big Bang may in the long run incite more youngsters to choose an education and career within this important field.

More information

Grant category: LEO Foundation Awards

Year: 2021

Geography: Japan

Dr. Satoshi Nakamizo is Assistant Professor at Kyoto University Graduate School of Medicine, Japan.

He receives the award for his excellent dermatological research, focused on the roles of antigen-presenting cells in chronic inflammatory skin diseases such as eczema and psoriasis.

Read more

Grant category: Research Grants in open competition

Year: 2021

Geography: USA

Among the biological treatments approved for the treatment of psoriasis, is ustekinumab, which is a monoclonal antibody targeting the shared p40 subunit of two cytokines, IL12 and IL23.

This project aims to improve psoriasis treatment by understanding why some psoriasis patients respond well to treatment with ustekinumab (responders) and others do not (non-responders). Interestingly, some non-responders to ustekinumab still respond well to inhibition of the IL23 pathway alone via the unique p19 subunit.

The pattern of differentially expressed genes among responders and non-responders may enable prediction of which intervention will be most beneficial for the individual patient. The plan is to compare single-cell transcriptomic analyses from both responders and non-responders to identify treatment response-linked gene expression patterns, so-called ‘endotypes’.

One size does not fit all for these biological therapeutics, and the goal is for the research to contribute to the development of a ‘companion diagnostic’, which is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person, and thereby to personalized medicine in psoriasis.

Grant category: Research Grants in open competition

Year: 2021

Geography: United Kingdom

This project, led by Edel O’Toole, aims to give new insights into the rare genetic skin disease, steatocystoma multiplex (SM) that may contribute to the development of a new treatment for affected individuals.

SM is a debilitating and embarrassing disorder, which presents as multiple smooth, yellow skin lumps or cysts distributed on the arms, trunk, neck, and underarm area. The lesions usually appear in the teenage years and for the severely affected patients with 100s to 1000s of cysts, these are a major burden causing disability and pain with frequent inflammation often mimicking infection.

The most common genetic defect is found in the gene coding for Keratin 17, a protein expressed in nails, hair follicles, skin on the palms and soles, and in sebaceous glands. The cysts in SM are believed to arise from the lining of these glands. The team will use single cell RNA sequencing and look at gene expression in individual cells lining the cyst and from the surrounding tissue, to understand the genetic differences.  In parallel, the O’Toole group will engineer cells from the sebaceous gland with and without the defect in the Keratin 17 gene. These cells will be used to form 3D skin models and cysts that mimic SM. Finally, drugs that target pathways of interest identified from the RNA sequencing will be used to ‘treat’ the 3D model, thereby adding to the many insights around SM expected from this project.

Grant category: Research Grants in open competition

Year: 2021

Geography: United Kingdom

Claire Higgins’ project aims to develop an early-stage diagnostic tool for scleroderma, a disease caused by an overproduction of collagen in both the skin and connective tissues, leading to a scarring of the skin and internal organs.

Among the early symptoms of scleroderma are poor blood circulation in fingers and toes, and an increased sensitivity to cold, which in many aspects is comparable to the much more common Raynaud’s phenomenon, and hence, scleroderma is often undiagnosed.

Utilizing the fact that certain molecules change expression level during disease (‘biomarker’ molecules), Claire Higgins aims to identify scleroderma-specific biomarkers in the liquid between individual skin cells, i.e., in the skin interstitial fluid. The identified biomarkers will be used to develop a non-invasive and painless test for general practitioners (GPs), enabling fast diagnosis – within minutes – and thereby differentiation between patients suffering from scleroderma and Raynaud’s phenomenon. Thus, patients will be able to get the most relevant intervention as early as possible. The actual diagnostic test will be developed along with the biomarker identification.

Grant category: Research Grants in open competition

Year: 2021

Geography: Denmark

The research project by Professor Christian Olsen pursues a cutting-edge strategy for the treatment of skin infections.

Staphylococcal bacteria are the most common cause of skin and soft tissue infections, and with the rise of methicillin-resistant Staphylococcus aureus (MRSA), this new strategy could – if successful – help prevent minor infections from becoming severe medical conditions. Furthermore, the strategy could minimize the risk of emerging antibiotic resistance.

Bacteria produce and release molecules known as ‘virulence factors’ which cause damage. The production of these harmful molecules is regulated through a form of cell-to-cell communication called ‘quorum sensing’, where the concentration of virulence factors increases as a function of cell density. The present project aims to weaken the severity of bacterial skin infections by inhibiting ‘quorum sensing’ with synthetic auto-inducing peptide (AIP) analogs, and as a result, decrease the excretion of virulence factors.

‘Quorum sensing’ inhibition will target the severity of the bacterial infection, rather than the viability of the individual bacterium and represents an alternative to antibiotics, as there is no evolutionary pressure on the individual bacterium to develop towards a state that is not affected by these compounds. Therefore, minimal risk of emerging antibiotic resistance is to be expected from this strategy.

Grant category: Research Grants in open competition

Year: 2021

Geography: USA

Melanocytes are pigment-producing skin cells. They serve as an excellent model for stem cell research because they are easily obtainable from the skin and have the potential to be modified into other types of cells. The aims of this project are to define molecular events that promote stem cell maintenance and to test if melanocyte stem cells can be transformed into other cell types (such as nerves).

Deborah Lang has created a unique transgenic mouse model that fluorescently marks melanocyte stem cells.  This model is an innovative and powerful tool to visualize and isolate pure stem cells without contaminating non-stem cells. The Lang lab, along with Andrey Sharov and other collaborators at Boston University, will investigate gene expression in the stem cells, and how these stem cells change into pigment-producing melanocytes. Further, the team will test the ability of the melanocyte stem cells to turn in to other cells, such as neurons and neuron-like cells.

This project will provide new insights into melanocyte stem cell function and flexibility to become other cell types. The potential long-term impact of this project is that it will provide insight on normal melanocyte function, melanocyte dysfunction and pathology, and stem cell therapy.